REGENXBIO, Inc. (RGNX)
7.24
-0.26
(-3.47%)
USD |
NASDAQ |
Sep 24, 16:00
7.42
+0.18
(+2.49%)
After-Hours: 19:59
REGENXBIO Gross Profit (Annual) : 134.53M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 134.53M |
| December 31, 2024 | 33.55M |
| December 31, 2023 | 35.71M |
| December 31, 2022 | 45.27M |
| December 31, 2021 | 408.95M |
| December 31, 2020 | 110.45M |
| December 31, 2019 | 19.84M |
| Date | Value |
|---|---|
| December 31, 2018 | 204.88M |
| December 31, 2017 | 5.998M |
| December 31, 2016 | 3.63M |
| December 31, 2015 | 6.085M |
| December 31, 2014 | 5.113M |
| December 31, 2013 | 5.763M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| AbbVie, Inc. | 42.89B |
| United Therapeutics Corp. | 2.798B |
| Capricor Therapeutics, Inc. | -1.890M |
| Ardelyx, Inc. | 364.72M |
| Biomea Fusion, Inc. | -1.409M |